Therapeutic Vaccines Market Trend, Share, Size, and Forecast 2032

Therapeutic Vaccines Market

Therapeutic Vaccines Market By Products (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines And Neurological Disease Vaccines) And By Technology (Autologous Vaccine And Allogeneic Vaccine), and By Region - Global and Regional Industry Overview, Comprehensive Analysis, Historical Data, and Forecasts 2024-2032

Category: Healthcare Report Format : PDF Pages: 145 Report Code: ZMR-1220 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 25.82 Billion USD 123.12 Billion 16.9% 2023

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, Technology
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Therapeutic Vaccines Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Therapeutic Vaccines Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Addiction Vaccines
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Autoimmune Disease Vaccines
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Infectious Disease Vaccines
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Neurulogical Disease Vaccines
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Therapeutic Vaccines Market – Tecchnulogy Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, Technology, 2020 & 2028
    • 5.2. Autulogous vaccines
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Allogeneic vaccines
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Therapeutic Vaccines Market – Regional Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 6.2.3. North America Market Revenue, Technology, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, Technology, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, Technology, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, Technology, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 6.3.3. Europe Market Revenue, Technology, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, Technology, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Product, 2016 – 2028
        • 6.3.6.2. France Market Revenue, Technology, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, Technology, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, Technology, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, Technology, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, Technology, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, Technology, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Product, 2016 – 2028
        • 6.4.5.2. China Market Revenue, Technology, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, Technology, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Product, 2016 – 2028
        • 6.4.7.2. India Market Revenue, Technology, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, Technology, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, Technology, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, Technology, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, Technology, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, Technology, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, Technology, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, Technology, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, Technology, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, Technology, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, Technology, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, Technology, 2016 – 2028
  • Chapter No. 7: Therapeutic Vaccines Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Therapeutic Vaccines Market: Company Market Share, 2019
      • 8.1.2. Global Therapeutic Vaccines Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Therapeutic Vaccines Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Therapeutic Vaccines Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Valeant Pharmaceuticals
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. BioVex, Inc
    • 9.3. Inovio Pharmaceuticals, Inc.
    • 9.4. Immunocellular Therapeutics, Ltd.
    • 9.5. Agenus Inc.
    • 9.6. GlaxoSmithKline plc.
    • 9.7. Pfizer Inc.
    • 9.8. Novartis AG
    • 9.9. Argos Therapeutics
    • 9.10. Bavarian Nordic
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, Technology
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Therapeutic Vaccines Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028 
FIG NO. 7. Global Therapeutic Vaccines Market for Addiction Vaccines, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Therapeutic Vaccines Market for Addiction Vaccines, By Country, 2020 & 2028
FIG NO. 9. Global Therapeutic Vaccines Market for Autoimmune Disease Vaccines, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Therapeutic Vaccines Market for Autoimmune Disease Vaccines, By Country, 2020 & 2028
FIG NO. 11. Global Therapeutic Vaccines Market for Infectious Disease Vaccines, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Therapeutic Vaccines Market for Infectious Disease Vaccines, By Country, 2020 & 2028
FIG NO. 13. Global Therapeutic Vaccines Market for Neurological Disease Vaccines, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Therapeutic Vaccines Market for Neurological Disease Vaccines, By Country, 2020 & 2028
FIG NO. 15. Market Revenue Share, Technology, 2020 & 2028
FIG NO. 16. Global Therapeutic Vaccines Market for Autologous vaccines, Revenue (USD Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Therapeutic Vaccines Market for Autologous vaccines, By Country, 2020 & 2028 
FIG NO. 18. Global Therapeutic Vaccines Market for Allogeneic vaccines, Revenue (USD Billion) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Therapeutic Vaccines Market for Allogeneic vaccines, By Country, 2020 & 2028
FIG NO. 20. Global Therapeutic Vaccines Market Revenue Share, By Region, 2020 & 2028
FIG NO. 21. North America Therapeutic Vaccines Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 22. Porter’s Five Forces Analysis for Global Therapeutic Vaccines Market
FIG NO. 23. PEST Analysis for Global Therapeutic Vaccines Market
FIG NO. 24. Pricing Analysis for Global Therapeutic Vaccines Market
FIG NO. 25. Value Chain Analysis for Global Therapeutic Vaccines Market
FIG NO. 26. Company Share Analysis, 2019
FIG NO. 27. Radar Determinant Chart, 2019
FIG NO. 28. Company Strategic Developments – Heat Map Analysis
FIG NO. 29. Medical Technologies, Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 30. Medical Technologies, Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 31. Market Channels
FIG NO. 32. Marketing Channel Development Trend
FIG NO. 33. Growth in World Gross Product, 2008-2018
FIG NO. 34. Research Methodology – Detailed View
FIG NO. 35. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global Therapeutic Vaccines Market: Snapshot
TABLE NO. 2. Quarterly Therapeutic Vaccines Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Therapeutic Vaccines Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Therapeutic Vaccines Market for Addiction Vaccines, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Therapeutic Vaccines Market for Autoimmune Disease Vaccines, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Therapeutic Vaccines Market for Infectious Disease Vaccines, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Therapeutic Vaccines Market for Neurological Disease Vaccines, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Therapeutic Vaccines Market for Autologous vaccines, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11 Global Therapeutic Vaccines Market for Allogeneic vaccines, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Therapeutic Vaccines Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. North America Therapeutic Vaccines Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 14. North America Therapeutic Vaccines Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 15. North America Therapeutic Vaccines Market Revenue, Technology, 2016 – 2028 (USD Billion)
TABLE NO. 16. U.S. Therapeutic Vaccines Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 17. U.S. Therapeutic Vaccines Market Revenue, Technology, 2016 – 2028 (USD Billion)
TABLE NO. 18. Canada Therapeutic Vaccines Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 19. Canada Therapeutic Vaccines Market Revenue, Technology, 2016 – 2028 (USD Billion)
TABLE NO. 20. Mexico Therapeutic Vaccines Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 21. Mexico Therapeutic Vaccines Market Revenue, Technology, 2016 – 2028 (USD Billion)
TABLE NO. 22. Drivers for the Therapeutic Vaccines Market: Impact Analysis
TABLE NO. 23. Restraints for the Therapeutic Vaccines Market: Impact Analysis
TABLE NO. 24. Major Buyers of Therapeutic Vaccines Market Market  
TABLE NO. 25. Distributors/Traders List of Therapeutic Vaccines Market Market
TABLE NO. 26. Global Therapeutic Vaccines Market, Company Market Revenue, 2016 – 2019 (USD Billion) 
TABLE NO. 27: Global Therapeutic Vaccines Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   


 

Methodology

FrequentlyAsked Questions

Therapeutic vaccines are designed to treat existing diseases by stimulating the immune system to fight specific conditions, such as cancer, infections, or chronic illnesses. Unlike preventive vaccines, which aim to prevent diseases, therapeutic vaccines target ongoing health issues to reduce symptoms, slow progression, or achieve remission.

According to study, the Therapeutic Vaccines Market size was worth around USD 25.82 billion in 2023 and is predicted to grow to around USD 123.12 billion by 2032.

The CAGR value of Therapeutic Vaccines Market is expected to be around 16.9% during 2024-2032.

North America has been leading the Therapeutic Vaccines Market and is anticipated to continue on the dominant position in the years to come.

The Therapeutic Vaccines Market is led by players like Valeant Pharmaceuticals, BioVex, Inc., Inovio Pharmaceuticals, Inc., Immunocellular Therapeutics, Ltd., Agenus Inc., GlaxoSmithKline plc., Pfizer Inc., Novartis AG, Argos Therapeutics, Bavarian Nordic, Transgene, Galena Biopharma, and Vaccinogen, Inc. among others

Choose License Type

  • zion payment modes

List of Contents

Market SizeOverviewCOVID-19 Impact Analysis Growth FactorsSegmentationReport ScopeRegional AnalysisCompetitive PlayersThe global Market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed